These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 4846267)
21. Skeletal muscle morphology of depressed patients after medication. Ross-Stanton J; Meltzer HY Muscle Nerve; 1979; 2(3):239-40. PubMed ID: 503109 [No Abstract] [Full Text] [Related]
22. Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin. Zis AP; Goodwin FK Arch Gen Psychiatry; 1979 Sep; 36(10):1097-1107. PubMed ID: 475543 [TBL] [Abstract][Full Text] [Related]
24. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Maas JW Arch Gen Psychiatry; 1975 Nov; 32(11):1357-61. PubMed ID: 1200759 [TBL] [Abstract][Full Text] [Related]
26. Studies on psychotropic drugs. XVII. Effects of 3-chloro-5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-5(H)-dibenz-(b,f)-azepine dihydrochloride monohydrate (Y-4153) on the metabolism of biogenic amines. Nakanishi M; Setoguchi M Arzneimittelforschung; 1973 Jun; 23(6):806-10. PubMed ID: 4740766 [No Abstract] [Full Text] [Related]
27. Clomipramine and maprotiline on human platelet uptake of 5-hydroxytryptamine and dopamine in vitro: what relevance to their antidepressive and other central actions? Turner P; Ehsanullah RS Postgrad Med J; 1977; 53 Suppl 4():14-8. PubMed ID: 600892 [No Abstract] [Full Text] [Related]
28. Protriptyline (Vivactil)--another antidepressant. Med Lett Drugs Ther; 1968 Mar; 10(5):17. PubMed ID: 5645606 [No Abstract] [Full Text] [Related]
29. Therapy-resistant depressions. Biochemical and pharmacological considerations. Contributions to biochemistry. van Praag HM Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):88-98. PubMed ID: 4438429 [No Abstract] [Full Text] [Related]
30. [Methodical problems of clinical-psychopharmacological research presented using the example of antidepressive agents]. Bente D Arzneimittelforschung; 1969 May; 19(5):806-8. PubMed ID: 4895502 [No Abstract] [Full Text] [Related]
31. [Current problems of endogenous depression]. Núnek K Act Nerv Super (Praha); 1970 Jan; 12(1):93-5. PubMed ID: 5418678 [No Abstract] [Full Text] [Related]
32. Biogenic amine hypotheses of affective disorders. Garver DL; Davis JM Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718 [No Abstract] [Full Text] [Related]
33. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209 [No Abstract] [Full Text] [Related]
34. A report from the British general practitioner research group on mebanazine in the treatment of depression. Wheatley D J New Drugs; 1965; 5(6):348-57. PubMed ID: 5327283 [No Abstract] [Full Text] [Related]
35. Neurophysiological and biochemical aspects in the action of antidepressant drugs. Benesová O Act Nerv Super (Praha); 1970; 12(3):226-34. PubMed ID: 4917579 [No Abstract] [Full Text] [Related]
36. Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment. Reveley MA; Glover V; Slander M; Coppen A Br J Clin Pharmacol; 1979 Oct; 8(4):375-8. PubMed ID: 508514 [No Abstract] [Full Text] [Related]
37. Differentiation of two genetically specific types of depression by the response to antidepressant drugs. Pare CM; Mack JW J Med Genet; 1971 Sep; 8(3):306-9. PubMed ID: 5097136 [No Abstract] [Full Text] [Related]
38. Novel strategies for pharmacotherapy of depression. Maubach KA; Rupniak NM; Kramer MS; Hill RG Curr Opin Chem Biol; 1999 Aug; 3(4):481-8. PubMed ID: 10419849 [TBL] [Abstract][Full Text] [Related]
39. A comparative trial of nortriptyline and amitriptyline in chronic schizophrenia. Haider I Br J Clin Pract; 1966 Aug; 20(8):416-7. PubMed ID: 5329316 [No Abstract] [Full Text] [Related]
40. Treatment of resistant depression. Contributions to genetic aspects. Pare CM Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):118-21. PubMed ID: 4438423 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]